Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

Blood Cancer Journal

Springer Nature

United KingdomHematology (Q1); Oncology (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
94H-index (SCImago 2025)
4.307SJR (2025)
2011-2026Coverage

About Blood Cancer Journal

Blood Cancer Journal is a scholarly journal published by Springer Nature. SCImago 2025 lists it in Q1, with an SJR of 4.307 and H-index of 94.

Coverage: 2011-2026. Research categories: Hematology (Q1); Oncology (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC-ND
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 4390 EUR; 5490 USD; 3690 GBP
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, PMC
Reported submission-to-publication time14 weeks on average; not a guarantee
Openly licensed content since2011 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2044-5385
ISSN-L2044-5385
Source typeJournal
Publisher / hosting organisationSpringer Nature
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex2,225
Citations recorded in OpenAlex72,999
OpenAlex H-index111
Years represented in OpenAlex1987–2026 (not the founding or closing dates)

Topics in published research

Multiple Myeloma Research and Treatments; Acute Myeloid Leukemia Research; Lymphoma Diagnosis and Treatment; Chronic Lymphocytic Leukemia Research; Myeloproliferative Neoplasms: Diagnosis and Treatment; Protein Degradation and Inhibitors.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit

Researchers & Scientists linked to this record

Connections from linked publications or recorded institutional relationships.

Ameet K. MishraMark Aaron Fiala